dna dapi (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
96
Structured Review
Santa Cruz Biotechnology
dna dapi
Dna Dapi, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1449 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+probe+dapi/DAPI/pmc04070927-231-8-14
Average 96 stars, based on 1449 article reviews
Dna Dapi, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1449 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+probe+dapi/DAPI/pmc04070927-231-8-14
Average 96 stars, based on 1449 article reviews
dna dapi - by Bioz Stars,
2026-09
96/100 stars
Images
1) Product Images from "Cohesin without Cohesion: A Novel Role for Pds5 in Saccharomyces cerevisiae"
Article Title: Cohesin without Cohesion: A Novel Role for Pds5 in Saccharomyces cerevisiae
Journal: PLoS ONE
doi: 10.1371/journal.pone.0100470
Figure Legend Snippet: (A) Flow cytometry analyses revealing DNA content of wildtype and pds5-1 mutant cells prior to and following 3 hour incubation in nocodazole (cultures were shifted to the restrictive temperature during the final hour of incubation in medium supplemented with nocodazole). (B) Percent viability of wildtype and pds5-1 mutant cells in the presence or absence of the final shift to the restrictive temperature during mitotic arrest. (C) Percent cohesion defects of wildtype and pds5-1 mutant cells after incubation at non-permissive temperature as described in (A) above (D) Micrographs of wildtype and pds5-1 mutant cells showing separated sisters (GFP-TetR), DNA (DAPI) and retention of Pds1 indicative of a pre-anaphase state.
Techniques Used: Flow Cytometry, Mutagenesis, Incubation
Figure Legend Snippet: (A) DNA content of wildtype cells and rad61 and pds5-1 single mutant cells and pds5-1 rad61 double mutant cells as described in . (B) Percent viability of wildtype cells and rad61 and pds5-1 single mutant cells and pds5-1 rad61 double mutant cells following the regimen described in . (C) Percent of wildtype and pds5-1 mutant cells showing condensed (Lines) and uncondensed rDNA (Puffs) rDNA structures following regimen described in . (D) Micrographs of wildtype and pds5-1 mutant cells highlight rDNA structure through Net1-GFP detection (GFP) and DNA (DAPI). Pds5 inactivation specifically during S-phase impacts chromosome condensation. Wildtype and pds5-1 mutant cells were synchronized in G1 (alpha factor arrest) at permissive temperature then released to a restrictive temperature and synchronized in pre-anaphase (nocodazole arrest) prior to microscopic analysis. (E) Percent of wildtype and pds5-1 mutant cells that exhibit either condensed (Lines) or decondensed (Puffs) rDNA structures. (F) Micrographs of wildtype and pds5-1 mutant cells reveal changes in rDNA architecture.
Techniques Used: Mutagenesis
Related Articles
Staining:Article Title: Exposure of Human Corneal Epithelial Cells to Microplastic Particles Induces a Phase-Specific Cytokine Response. Article Snippet: 37 Microplastics have been identified in ophthalmic therapeutics and linked to dry eye 38 disease and meibomian gland dysfunction.. Inflammation is hypothesised to drive 39 ocular surface damage.. This in-vitro study investigates how varying concentrations of 40 microplastics affect corneal cell viability and cytokine expression. Article Title: Macrophage-derived IL-6 reprograms lipid metabolism to promote colorectal cancer development through USP14-mediated FASN deubiquitination Article Snippet: For immunohistochemistry, the slices were incubated with antibodies against IL-6 (Cat#AF-206-NA, R&D Systems, Minneapolis, Minnesota, USA), p-STAT3 (Cell Signaling Technology, Danvers, Massachusetts, USA), USP14 (Proteintech, Wuhan, Hubei, China) and FASN (Cat#10624-2-AP, Proteintech) and then treated with an HRP-labeled secondary antibody (Proteintech). .. After the final round of staining, Article Title: Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases. Article Snippet: Immunofluorescence stainings of muscle cryosections were performed with anti-CD19 (302202, 1:50; BioLegend) antibodies. .. Nuclei were stained with Article Title: Glycine receptors in circulating white blood cells regulated by neuroinflammation Article Snippet: After incubation, the slides were washed three times with PBS for 5 minutes each, then incubated with appropriate secondary antibodies, i.e., Alexa Fluor 488 (1:200) and/or 594 (1:200) (Thermo-Fisher Scientific) for 1 hour at room temperature. .. A Fluorescence:Article Title: Exposure of Human Corneal Epithelial Cells to Microplastic Particles Induces a Phase-Specific Cytokine Response. Article Snippet: 37 Microplastics have been identified in ophthalmic therapeutics and linked to dry eye 38 disease and meibomian gland dysfunction.. Inflammation is hypothesised to drive 39 ocular surface damage.. This in-vitro study investigates how varying concentrations of 40 microplastics affect corneal cell viability and cytokine expression. Microscopy:Article Title: Exposure of Human Corneal Epithelial Cells to Microplastic Particles Induces a Phase-Specific Cytokine Response. Article Snippet: 37 Microplastics have been identified in ophthalmic therapeutics and linked to dry eye 38 disease and meibomian gland dysfunction.. Inflammation is hypothesised to drive 39 ocular surface damage.. This in-vitro study investigates how varying concentrations of 40 microplastics affect corneal cell viability and cytokine expression. Incubation:Article Title: Submedius thalamic inputs shape the presynaptic architecture of layer 5 orbitofrontal cortex in mice Article Snippet: For quantitative analysis of trans-synaptic tracing, 40-μm coronal sections of the whole brain were collected using cryostat (model #CM1860; Leica). .. Free-floating slices were incubated at room temperature with gentle agitation as follows: 2 h in blocking solution (5% heat-inactivated goat serum, 0.4% Triton X-100 in PBS); overnight in primary antibody diluted 1:1000 in blocking solution (mouse anti-GFP, GFP-1010, Aves Labs; or anti-RFP, 5f8, Chromotek); 2–3 h in secondary antibody diluted 1:500 (donkey anti-chicken-IgY Alexa488 or goat anti-rat IgG Cy3, Jackson ImmunoResearch); and 15 min in 2.5 μg/mL of DAPI (Santa Cruz, Cat #sc-3598) in Gentle:Article Title: Submedius thalamic inputs shape the presynaptic architecture of layer 5 orbitofrontal cortex in mice Article Snippet: For quantitative analysis of trans-synaptic tracing, 40-μm coronal sections of the whole brain were collected using cryostat (model #CM1860; Leica). .. Free-floating slices were incubated at room temperature with gentle agitation as follows: 2 h in blocking solution (5% heat-inactivated goat serum, 0.4% Triton X-100 in PBS); overnight in primary antibody diluted 1:1000 in blocking solution (mouse anti-GFP, GFP-1010, Aves Labs; or anti-RFP, 5f8, Chromotek); 2–3 h in secondary antibody diluted 1:500 (donkey anti-chicken-IgY Alexa488 or goat anti-rat IgG Cy3, Jackson ImmunoResearch); and 15 min in 2.5 μg/mL of DAPI (Santa Cruz, Cat #sc-3598) in Blocking Assay:Article Title: Submedius thalamic inputs shape the presynaptic architecture of layer 5 orbitofrontal cortex in mice Article Snippet: For quantitative analysis of trans-synaptic tracing, 40-μm coronal sections of the whole brain were collected using cryostat (model #CM1860; Leica). .. Free-floating slices were incubated at room temperature with gentle agitation as follows: 2 h in blocking solution (5% heat-inactivated goat serum, 0.4% Triton X-100 in PBS); overnight in primary antibody diluted 1:1000 in blocking solution (mouse anti-GFP, GFP-1010, Aves Labs; or anti-RFP, 5f8, Chromotek); 2–3 h in secondary antibody diluted 1:500 (donkey anti-chicken-IgY Alexa488 or goat anti-rat IgG Cy3, Jackson ImmunoResearch); and 15 min in 2.5 μg/mL of DAPI (Santa Cruz, Cat #sc-3598) in FACS:Article Title: Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody Article Snippet: Cells were surface-stained with fluorescent dye-conjugated antibodies anti-human CD4 (clone RPA-T4, BioLegend, Cat.-No. 300532), CD8 (clone RPa-T8, BioLegend, Cat.-No. 3010441), CD62L (clone DREG-56, BioLegend, Cat.-No. 304834), CD127 (clone 019D5, BioLegend, Cat.-No. A019D5), CD134 (clone Ber-ACT35, BioLegend, Cat.-No. 350008), CD137 (clone 4B4-1, BioLegend, Cat.-No. 309814), GITR (clone 621, BioLegend, Cat.-No. 3311608) and CD25 (clone M-A251, BioLegend, Cat.-No. 356112) for 20 min at 4° C. in FACS buffer. .. Then, they were washed once with FACS buffer before being resuspended in 85 μL/well FACS buffer containing containing 0.2 μg/mL Software:Article Title: Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody Article Snippet: Cells were surface-stained with fluorescent dye-conjugated antibodies anti-human CD4 (clone RPA-T4, BioLegend, Cat.-No. 300532), CD8 (clone RPa-T8, BioLegend, Cat.-No. 3010441), CD62L (clone DREG-56, BioLegend, Cat.-No. 304834), CD127 (clone 019D5, BioLegend, Cat.-No. A019D5), CD134 (clone Ber-ACT35, BioLegend, Cat.-No. 350008), CD137 (clone 4B4-1, BioLegend, Cat.-No. 309814), GITR (clone 621, BioLegend, Cat.-No. 3311608) and CD25 (clone M-A251, BioLegend, Cat.-No. 356112) for 20 min at 4° C. in FACS buffer. .. Then, they were washed once with FACS buffer before being resuspended in 85 μL/well FACS buffer containing containing 0.2 μg/mL |
